12 Month Price Forecast For CCEL
Distance to CCEL Price Forecasts
CCEL Price Momentum
🤔 Considering Cryo-Cell (CCEL)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 4:12 AM UTC
CCEL Analyst Ratings & Price Targets
Based on our analysis of 1 Wall Street analysts, CCEL has a consensus that is bullish. The median price target is $9.00, with forecasts ranging from $9.00 to $9.00. Currently, there are 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
With CCEL currently trading at $7.47, the median price forecast suggests a 20.5% upside. The most optimistic forecast comes from at , projecting a 20.5% upside, while at provides the most conservative target, suggesting a 20.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CCEL Analyst Consensus
CCEL Price Target Range
Latest CCEL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CCEL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 29, 2022 | Maxim Group | Allen Klee | Buy | Initiates | $12.00 |
Stocks Similar to CRYO-CELL International, Inc.
The following stocks are similar to Cryo-Cell based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
CRYO-CELL International, Inc. (CCEL) Financial Data
CRYO-CELL International, Inc. has a market capitalization of $56.92M with a P/E ratio of 16.1x. The company generates $31.84M in trailing twelve-month revenue with a -28.0% profit margin.
Revenue growth is +2.5% quarter-over-quarter, while maintaining an operating margin of +17.4% and return on equity of +86.3%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
CRYO-CELL International, Inc. (CCEL) Company Overview
About CRYO-CELL International, Inc.
Provides cryogenic storage for stem cells.
The company generates revenue by offering cellular processing and cryogenic storage services, specifically for umbilical cord blood and tissue. It markets these services directly to expectant parents and through healthcare professionals, ensuring a steady customer base for its preservation solutions.
Founded in 1989 and headquartered in Oldsmar, Florida, Cryo-Cell International, Inc. also manufactures the PrepaCyte CB processing system, enhancing its operational capabilities in the stem cell industry. The preservation of umbilical cord stem cells is vital in regenerative medicine, which addresses various serious health conditions.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
82
CEO
Mr. David I. Portnoy
Country
United States
IPO Year
1994
Website
www.cryo-cell.comCRYO-CELL International, Inc. (CCEL) Latest News & Analysis
Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend
2 months agoCryo-Cell International, Inc. (CCEL) announced a quarterly cash dividend of $0.25 per share, payable on November 29, 2024, to shareholders of record as of November 15, 2024.
Cryo-Cell's announcement of a quarterly dividend indicates financial stability and profitability, potentially attracting income-focused investors and boosting stock demand.
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results
3 months agoCryo-Cell International reported Q3 2024 revenues of $8.07 million, up from $7.87 million in Q3 2023. Net income details were not fully provided.
Cryo-Cell's revenue growth signals improving business performance, potentially boosting investor confidence and impacting stock valuation positively.
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results
6 months agoCryo-Cell International reported Q2 fiscal 2024 revenues of $8.0 million, a 3% increase from $7.8 million in Q2 fiscal 2023.
Cryo-Cell's revenue growth signals strengthening demand for stem cell banking, potentially boosting investor confidence and indicating positive market trends in the healthcare sector.
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results
9 months agoCryo-Cell International, Inc. reported Q1 fiscal 2024 revenues of $7.85 million, up slightly from $7.82 million in Q1 2023.
Cryo-Cell's slight revenue growth signals stability and potential for future expansion, which can influence stock performance and investor confidence in the healthcare sector.
Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value
9 months agoCryo-Cell International plans to spin off its subsidiary, Celle Corp., to shareholders and is exploring strategic alternatives to enhance shareholder value post spin-off.
The spin-off of Celle Corp. may unlock value for Cryo-Cell shareholders, potentially leading to new investment opportunities and strategic partnerships that could enhance overall returns.
Cryo-Cell International reported fiscal 2023 revenues of $31.3 million, up from $30.3 million in 2022, with $30.8 million from processing and storage fees.
Cryo-Cell's revenue increase signals growth potential, indicating a positive trend in demand for its services, which could enhance investor confidence and influence stock performance.
Frequently Asked Questions About CCEL Stock
What is CRYO-CELL International, Inc.'s (CCEL) stock forecast for 2025?
Based on our analysis of 1 Wall Street analysts, CRYO-CELL International, Inc. (CCEL) has a median price target of $9.00. The highest price target is $9.00 and the lowest is $9.00.
Is CCEL stock a good investment in 2025?
According to current analyst ratings, CCEL has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.47. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for CCEL stock?
Wall Street analysts predict CCEL stock could reach $9.00 in the next 12 months. This represents a 20.5% increase from the current price of $7.47. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is CRYO-CELL International, Inc.'s business model?
The company generates revenue by offering cellular processing and cryogenic storage services, specifically for umbilical cord blood and tissue. It markets these services directly to expectant parents and through healthcare professionals, ensuring a steady customer base for its preservation solutions.
What is the highest forecasted price for CCEL CRYO-CELL International, Inc.?
The highest price target for CCEL is $9.00 from at , which represents a 20.5% increase from the current price of $7.47.
What is the lowest forecasted price for CCEL CRYO-CELL International, Inc.?
The lowest price target for CCEL is $9.00 from at , which represents a 20.5% increase from the current price of $7.47.
What is the overall CCEL consensus from analysts for CRYO-CELL International, Inc.?
The overall analyst consensus for CCEL is bullish. Out of 1 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $9.00.
How accurate are CCEL stock price projections?
Stock price projections, including those for CRYO-CELL International, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
